John Thomas Wei
Impact in
- Urology top 0.02%
- Urinary Bladder and Prostate Research
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 158
- Prostate Cancer Treatment and Research 45
- Renal cell carcinoma treatment 9
- Urology 61
- Urinary Bladder and Prostate Research 53
- Urological Disorders and Treatments 11
- Co-authors
- Rodney L. Dunn (92 shared papers)Martin George Sanda (58 shared papers)James E. Montie (72 shared papers)Howard Mark Sandler (24 shared papers)Brent K. Hollenbeck (66 shared papers)Mark S. Litwin (14 shared papers)Mark Andrew Rubin (22 shared papers)David Christopher Miller (43 shared papers)
- Journals
- The Journal of Urology (112 papers)Urology (52 papers)Cancer (17 papers)International Journal of Radiation Oncology*Biology*Physics (9 papers)British Journal of Urology (8 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
John Thomas Wei
366 papers receiving 30.1k citations
John Thomas Wei's Hit Papers
Peers
Comparison fields: 5 of 192
- Urology 4.0k
- Pulmonary and Respiratory Medicine 14.0k
- Cancer Research 4.0k
- Rheumatology 2.6k
- Oncology 2.5k
Countries citing papers authored by John Thomas Wei
This map shows the geographic impact of John Thomas Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Thomas Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Thomas Wei more than expected).
Fields of papers citing papers by John Thomas Wei
This network shows the impact of papers produced by John Thomas Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Thomas Wei. The network helps show where John Thomas Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside John Thomas Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 377 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Hit paper breakdown → | 2009 | 1916 |
| 2 | Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors Hit paper breakdown → | 2008 | 1846 |
| 3 | Radical Prostatectomy versus Observation for Localized Prostate Cancer Hit paper breakdown → | 2012 | 1375 |
| 4 | Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Hit paper breakdown → | 2000 | 1326 |
| 5 | Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia Hit paper breakdown → | 2011 | 885 |
| 6 | Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression Hit paper breakdown → | 2011 | 883 |
| 7 | Integrative molecular concept modeling of prostate cancer progression Hit paper breakdown → | 2006 | 762 |
| 8 | Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression Hit paper breakdown → | 2005 | 676 |
| 9 | UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA Hit paper breakdown → | 2005 | 639 |
| 10 | A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy Hit paper breakdown → | 2016 | 557 |
| 11 | Autoantibody Signatures in Prostate Cancer Hit paper breakdown → | 2005 | 510 |
| 12 | A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range Hit paper breakdown → | 2011 | 390 |
| 13 | 2012 | 386 | |
| 14 | 2006 | 380 | |
| 15 | 2004 | 368 | |
| 16 | 2006 | 368 | |
| 17 | 2010 | 367 | |
| 18 | 2002 | 365 | |
| 19 | Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer Hit paper breakdown → | 2006 | 358 |
| 20 | 2008 | 324 |
About John Thomas Wei
John Thomas Wei is a scholar working on Pulmonary and Respiratory Medicine, Urology, Rheumatology, Surgery and Cancer Research, having authored 377 papers that have together received 31.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (158 papers), Urinary Bladder and Prostate Research (53 papers), Prostate Cancer Treatment and Research (45 papers), Pelvic floor disorders treatments (42 papers), Bladder and Urothelial Cancer Treatments (26 papers), Urological Disorders and Treatments (11 papers), Renal cell carcinoma treatment (9 papers) and Molecular Biology Techniques and Applications (9 papers). The work is most often cited by research in Urology (4.0k citations), Pulmonary and Respiratory Medicine (14.0k citations), Cancer Research (4.0k citations), Rheumatology (2.6k citations) and Oncology (2.5k citations). John Thomas Wei has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Rodney L. Dunn, Martin George Sanda, James E. Montie, Howard Mark Sandler, Brent K. Hollenbeck, Mark S. Litwin, Mark Andrew Rubin, David Christopher Miller, Arul M. Chinnaiyan and Scott Arthur Tomlins. Their work appears in journals such as The Journal of Urology, Urology, Cancer, International Journal of Radiation Oncology*Biology*Physics and British Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.